Equitable Trust’s Eastman Chemical EMN Stock Holding History

Equitable Trust’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,359	Closed	-$256K	–	471
2026 Q1	$256K	Buy	3,359 +66	+2%	+$4.76K	0.01%	427
2025 Q4	$210K	Hold	3,293	–	–	0.01%	429
2025 Q3	$208K	Hold	3,293	–	–	0.01%	429
2025 Q2	$246K	Sell	3,293 -36	-1%	-$2.83K	0.01%	406
2025 Q1	$293K	Hold	3,329	–	–	0.02%	405
2024 Q4	$304K	Buy	3,329 +92	+3%	+$9.43K	0.02%	411
2024 Q3	$362K	Buy	3,237 +15	+0.5%	+$1.5K	0.02%	365
2024 Q2	$316K	Sell	3,222 -628	-16%	-$62.3K	0.02%	374
2024 Q1	$386K	Buy	+3,850	New	+$339K	0.03%	340
2021 Q1	–	Sell	-7,000	Closed	-$702K	–	359
2020 Q4	$702K	Hold	7,000	–	–	0.05%	215
2020 Q3	$547K	Hold	7,000	–	–	0.05%	227
2020 Q2	$487K	Hold	7,000	–	–	0.04%	221
2020 Q1	$326K	Buy	+7,000	New	+$450K	0.04%	246

Other funds holding EMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Equitable Trust's EMN Position: Q2 2026 in Review

Equitable Trust sold out of Eastman Chemical (EMN) in Q2 2026, closing a stake of 3,359 shares — an estimated $256K sold.

Equitable Trust first reported a position in EMN in Q1 2020 and held it in 13 quarters. The position peaked at $702K in Q4 2020. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

Equitable Trust reported no remaining Eastman Chemical position as of Q2 2026 after selling out during the quarter.
Equitable Trust sold 3,359 Eastman Chemical shares in Q2 2026, an estimated $256K.
Equitable Trust first reported a position in Eastman Chemical in Q1 2020 and held it in 13 quarters.
Equitable Trust's Eastman Chemical position peaked at $702K in Q4 2020.
644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.